She's thrilled with the results—in addition to losing weight, her blood work and sleep apnea have improved—but the changes to her life and body feel too fraught to talk about with her friends, who want nothing to do with her weight loss.

Novo Nordisk has said it will cut prices of Wegovy amid rising sales and competition.Sales of the blockbuster weight-loss drug more than doubled in the first quarter year on year.Novo faces competition from Eli Lilly and scrutiny from the US government over drug pricing.

Ozempic was approved by Health Canada in 2018 specifically as a medication for people with type 2 diabetes. Weight loss can be a byproduct of taking Ozempic, whereas Wegovy is a slightly higher dose of semaglutide specifically geared toward people who are obese or overweight but may have type 2 diabetes.

Novo Nordisk’s weight loss drug Wegovy will be available in Canada starting today, a move that will relieve the high demand for Ozempic.

Weight-loss medication Wegovy has quickly become a popular aid to weight management for many patients - including some teenagers. The Food and Drug Administration (FDA) approved the medication for use in patients under 18 in late 2022. Dr. Jennifer McCauley with UNC Health works closely with patients with weight management issues.

There's an abundance of drugs whose mechanisms are surprisingly complex. Popular diabetes and weight-loss treatments like Ozempic and Wegovy are two such drugs.

Rapidly dropping pounds is associated with a loss of muscle mass and other undesirable effects—including looking older.